The Unspoken Bottleneck in Precision Medicine: “You Have the Assay. Do You Have the Pathologist?”
- The precision medicine field is producing increasingly complex tissue biomarkers faster than the specialist pathology workforce can support them
- pCR, tumor microenvironment, spatial biomarkers, all require pathologists with specific post-treatment or platform expertise
- Capacity and subspecialty access is the bottleneck nobody is talking about at a program planning level
- What a fit-for-purpose pathology model looks like for biomarker and CDx programs at scale